Patents by Inventor Eggert Stockfleth

Eggert Stockfleth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9060998
    Abstract: The present invention refers to a method for treating cancerous or precancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: June 23, 2015
    Assignee: Medigene AG
    Inventor: Eggert Stockfleth
  • Publication number: 20130245113
    Abstract: The present invention refers to a method for treating cancerous or precancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto.
    Type: Application
    Filed: May 7, 2013
    Publication date: September 19, 2013
    Applicant: MediGene AG
    Inventor: Eggert STOCKFLETH
  • Patent number: 8455022
    Abstract: The present invention refers to a method for treating cancerous or precancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: June 4, 2013
    Assignee: MediGene AG
    Inventor: Eggert Stockfleth
  • Publication number: 20110166219
    Abstract: The present invention refers to a method for treating cancerous or precancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto.
    Type: Application
    Filed: March 18, 2011
    Publication date: July 7, 2011
    Applicant: MediGene AG
    Inventor: Eggert Stockfleth
  • Patent number: 7910138
    Abstract: A method for treating cancerous or pre-cancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto is described herein.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: March 22, 2011
    Assignee: MediGene AG
    Inventor: Eggert Stockfleth
  • Patent number: 7378401
    Abstract: The present invention is directed to the systemic administration of Fosfluridine Tidoxil, (5-fluorouridine)-5?-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt thereof, for the treatment of intraepithelial proliferative diseases such as actinic keratosis. The Fosfluridine Tidoxil can be systemically administered alone or in combination with topical treatment agents.
    Type: Grant
    Filed: July 14, 2006
    Date of Patent: May 27, 2008
    Assignee: Heidelberg Pharma GmbH
    Inventors: Erwin Boehm, Michael Kulke, Eggert Stockfleth
  • Publication number: 20080014258
    Abstract: The present invention is directed to the systemic administration of Fosfluridine Tidoxil, (5-fluorouridine)-5?-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt thereof, for the treatment of intraepithelial proliferative diseases such as actinic keratosis. The Fosfluridine Tidoxil can be systemically administered alone or in combination with topical treatment agents.
    Type: Application
    Filed: July 14, 2006
    Publication date: January 17, 2008
    Applicant: HEIDELBERG PHARMA GMBH
    Inventors: Erwin Boehm, Michael Kulke, Eggert Stockfleth
  • Publication number: 20070059387
    Abstract: The present invention refers to a method for treating cancerous or pre-cancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto.
    Type: Application
    Filed: October 8, 2004
    Publication date: March 15, 2007
    Applicant: MEDIGENE AG
    Inventor: Eggert Stockfleth
  • Publication number: 20050079235
    Abstract: The present invention refers to a method for treating actinic keratosis by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto.
    Type: Application
    Filed: October 9, 2003
    Publication date: April 14, 2005
    Inventor: Eggert Stockfleth